Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Clin Dev Immunol ; 2013: 374769, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24151516

RESUMEN

Extensive research in recent years suggests that exposure to xenobiotic stimuli plays a critical role in autoimmunity induction and severity and that the resulting response would be exacerbated in individuals with an infection-aroused immune system. In this context, heavy metals constitute a prominent category of xenobiotic substances, known to alter divergent immune cell responses in accidentally and occupationally exposed individuals, thereby increasing the susceptibility to autoimmunity and cancer, especially when accompanied by inflammation-triggered persistent sensitization. This perception is learned from experimental models of infection and epidemiologic studies and clearly underscores the interplay of exposure to such immunomodulatory elements with pre- or postexposure infectious events. Further, the TH17 cell subset, known to be associated with a growing list of autoimmune manifestations, may be the "superstar" at the interface of xenobiotic exposure and autoimmunity. In this review, the most recently established links to this nomination are short-listed to create a framework to better understand new insights into TH17's contributions to autoimmunity.


Asunto(s)
Autoinmunidad/inmunología , Inmunomodulación , Infecciones/inmunología , Células Th17/inmunología , Xenobióticos/inmunología , Bacterias/inmunología , Comunicación Celular/inmunología , Humanos , Infecciones/metabolismo , Infecciones/microbiología , Inflamación/inmunología , Inflamación/metabolismo , Metales Pesados/inmunología , Transducción de Señal , Linfocitos T Colaboradores-Inductores/inmunología , Linfocitos T Colaboradores-Inductores/metabolismo , Células Th17/metabolismo , Células Th17/microbiología
2.
Drug Des Devel Ther ; 10: 3425-3434, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27799742

RESUMEN

Environmental exposure to arsenic represents a serious challenge to humans and other animals. The aim of the present study was to test the protective effect of antioxidant N-acetylcysteine (NAC) either individually or in combination with a chelating agent, meso-2,3-dimercaptosuccinic acid (DMSA), against sodium arsenite oral toxicity in male rats. Five groups were used: control; arsenic group (orally administrated in a concentration of 2 mg/kg body weight [b.w.]); the other three groups were orally administrated sodium arsenite in a concentration of 2 mg/kg b.w. followed by either NAC (10 mg/kg b.w., intraperitoneally [i.p.]), DMSA (50 mg/kg b.w., i.p.) or NAC plus DMSA. Arsenic toxicity caused significant rise in serum aspartate aminotransferase, alanine aminotransferase and total bilirubin, and a significant decrease in total protein (TP) and albumin levels after 3 weeks of experimental period. In addition, arsenic-treated rats showed significantly higher arsenic content in liver and significant rise in hepatic malondialdehyde level. By contrast, sharp decreases in glutathione content and catalase and glutathione reductase activities were discernible. NAC and/or DMSA counteracted most of these physiologic and biochemical defects. NAC monotherapy was more effective than DMSA in increasing TP, while DMSA was more effective in decreasing alanine aminotransferase. The combined treatment was superior over monotherapies in recovery of TP and glutathione. Biochemical data were well supported by histopathological and ultrastructural findings. In conclusion, the combination therapy of NAC and DMSA may be an ideal choice against oxidative insult induced by arsenic poisoning.


Asunto(s)
Acetilcisteína/farmacología , Acetilcisteína/uso terapéutico , Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Enfermedad Hepática Inducida por Sustancias y Drogas/fisiopatología , Estrés Oxidativo/efectos de los fármacos , Succímero/farmacología , Succímero/uso terapéutico , Acetilcisteína/administración & dosificación , Animales , Arsenitos/administración & dosificación , Arsenitos/toxicidad , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Masculino , Ratas , Ratas Wistar , Compuestos de Sodio/administración & dosificación , Compuestos de Sodio/toxicidad , Succímero/administración & dosificación
3.
Autoimmun Rev ; 9(11): 785-92, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20647062

RESUMEN

With all the incredible progress in scientific research over the past two decades, the trigger of the majority of autoimmune disorders remains largely elusive. Research on the biology of T helper type 17 (T(H)17) cells over the last decade not only clarified previous observations of immune regulations and disease manifestations, but also provided considerable information on the signaling pathways mediating the effects of this lineage and its seemingly dual role in fighting the invading pathogens on one hand, and in frightening the host by inducing chronic inflammation and autoimmunity on the other hand. In this context, recent reports have implicated T(H)17 cells in mediating host defense as well as a growing list of autoimmune diseases in genetically-susceptible individuals. Herein, we summarize the current knowledge on T(H)17 in autoimmunity with emphasis on its differentiation factors and some mechanisms involved in initiating pathological events of autoimmunity.


Asunto(s)
Enfermedades Autoinmunes/inmunología , Autoinmunidad , Interleucina-17/inmunología , Transducción de Señal , Células Th17/inmunología , Células Th17/metabolismo , Animales , Linfocitos T CD4-Positivos/inmunología , Citocinas/metabolismo , Inflamación/inmunología , Inflamación/metabolismo , Ratones , Receptores de Citocinas/metabolismo , Factor de Transcripción STAT3/metabolismo , Activación Transcripcional , Factores de Crecimiento Transformadores/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA